Brief: Medigene: FY Total Revenues At EUR 10.5 Mln

Medigene AG

23/03/2022 07:13

March 23 (Reuters) - MEDIGENE AG  MDG1k.DE :
    * AXEL MALKOMES, MEDIGENE’S CHIEF FINANCIAL AND BUSINESS
DEVELOPMENT OFFICER, WILL LEAVE COMPANY AT THE END OF MARCH 2022
BY MUTUAL CONSENT AT THE EXPIRY OF HIS CONTRACT
    * DOLORES SCHENDEL WILL REMAIN AS CEO AND CSO
    * FY TOTAL REVENUES OF EUR 10.5 MILLION (2020: EUR 8.0
MILLION)
    * FY EBITDA LOSS INCURRED IN FISCAL YEAR 2021 OF EUR -6.6
MILLION
(2020: EUR -22.2 MILLION)
    * FY CASH AND CASH EQUIVALENTS AMOUNTED TO EUR 22.4 MILLION
AT THE
END OF 2021
    * OUTLOOK 2022: EXPECTS TO ACHIEVE REVENUES OF EUR 23 – 28
MILLION, R&D EXPENSES OF EUR 11 – 15 MILLION AND A POSITIVE
EBITDA IN THE AMOUNT OF EUR 3 – 5 MILLION

       
 Source text for Eikon:  urn:newsml:reuters.com:*:nPex0Y2MJa
 Further company coverage:  MDG1k.DE  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))